ReviewCells2023

Opportunities and Challenges for the Development of MRCK Kinases Inhibitors as Potential Cancer Chemotherapeutics.

Vanessa M Ruscetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.